Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ABT

Abbott Laboratories

Dec 20 • 04:00PM ET

114.23

Dollar change +1.81
Percentage change 1.61	%

Healthcare • Medical Devices • USA • NYSE

Peers: JNJ MDT DHR BAX SYK ISRG TDOC BDX RMD ZBH

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM IHI VHT

Scroll to Statements

Index	S&P 500	P/E	34.74	EPS (ttm)	3.29	Insider Own	0.66%	Shs Outstand	1.73B	Perf Week	0.75%
Market Cap	201.32B	Forward P/E	22.13	EPS next Y	5.16	Insider Trans	-2.51%	Shs Float	1.72B	Perf Month	-1.47%
Income	5.75B	PEG	4.26	EPS next Q	1.34	Inst Own	76.62%	Short Float	0.79%	Perf Quarter	-0.51%
Sales	41.22B	P/S	4.88	EPS this Y	5.28%	Inst Trans	-1.00%	Short Ratio	2.67	Perf Half Y	8.48%
Book/sh	22.94	P/B	4.98	EPS next Y	10.40%	ROA	7.85%	Short Interest	13.57M	Perf Year	6.36%
Cash/sh	4.42	P/C	25.85	EPS next 5Y	8.15%	ROE	14.87%	52W Range	99.71 - 121.64	Perf YTD	3.78%
Dividend Est.	2.21 (1.94%)	P/FCF	31.04	EPS past 5Y	19.65%	ROI	10.92%	52W High	-6.09%	Beta	0.73
Dividend TTM	2.20 (1.93%)	Quick Ratio	1.14	Sales past 5Y	6.10%	Gross Margin	50.98%	52W Low	14.56%	ATR (14)	1.91
Dividend Ex-Date	Jan 15, 2025	Current Ratio	1.60	EPS Y/Y TTM	11.65%	Oper. Margin	16.38%	RSI (14)	46.70	Volatility	1.75% 1.58%
Employees	114000	Debt/Eq	0.38	Sales Y/Y TTM	3.15%	Profit Margin	13.94%	Recom	1.72	Target Price	131.82
Option/Short	Yes / Yes	LT Debt/Eq	0.32	EPS Q/Q	14.65%	Payout	63.81%	Rel Volume	2.35	Prev Close	112.42
Sales Surprise	0.80%	EPS Surprise	0.65%	Sales Q/Q	4.85%	Earnings	Oct 16 BMO	Avg Volume	5.08M	Price	114.23
SMA20	-1.02%	SMA50	-1.51%	SMA200	3.22%	Trades		Volume	11,945,003	Change	1.61%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-08-24	Initiated	Oppenheimer	Outperform	$130
Sep-19-24	Initiated	Piper Sandler	Overweight	$131
Jul-30-24	Downgrade	Edward Jones	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$121
Jul-21-23	Upgrade	Wolfe Research	Underperform → Peer Perform
May-30-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$112
Apr-20-23	Reiterated	Wolfe Research	Underperform	$107 → $103
Apr-20-23	Reiterated	UBS	Buy	$117 → $130
Apr-20-23	Reiterated	Raymond James	Outperform	$116 → $123
Apr-20-23	Reiterated	JP Morgan	Overweight	$118 → $122
Apr-20-23	Reiterated	Bernstein	Outperform	$132 → $133
Apr-20-23	Reiterated	Barclays	Overweight	$125 → $127
Mar-29-23	Initiated	UBS	Buy	$117
Oct-26-22	Initiated	Mizuho	Neutral	$105
Oct-18-22	Initiated	Barclays	Overweight	$118
Oct-12-22	Initiated	Jefferies	Hold	$110
Jul-06-22	Initiated	Wolfe Research	Underperform	$95
Mar-02-22	Resumed	BofA Securities	Buy	$140
Jan-27-22	Reiterated	UBS	Buy	$138 → $142
Jan-27-22	Reiterated	Raymond James	Outperform	$150 → $143

Show Previous Ratings

Dec-19-24 06:00AM	2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond (Motley Fool)
Dec-18-24 05:15AM	The Smartest Dividend Stocks to Buy With $500 Right Now (Motley Fool)
Dec-17-24 05:50PM	Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
04:03PM	Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta (PR Newswire)
07:00AM	Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart (PR Newswire)
01:21PM	Loading…
Dec-13-24 01:21PM	Abbott Increases Dividend Again, Showcasing Decades of Reliable Shareholder Returns (GuruFocus.com)
10:58AM	Abbott Increases Quarterly Dividend for 53rd Consecutive Year (PR Newswire)
Dec-12-24 09:00AM	On Ozempic? Big Food Makers Have a New Label for You (The Wall Street Journal)
09:00AM	Big Foods Latest Label: GLP-1 Friendly (The Wall Street Journal)
Dec-11-24 05:50PM	Abbott (ABT) Stock Sinks As Market Gains: Here's Why (Zacks)
06:01AM	Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories (GuruFocus.com)
Dec-09-24 10:38PM	Why Is Abbott Laboratories (ABT) Among the Best Dividend Kings to Invest In For Safe Dividend Growth? (Insider Monkey)
Dec-07-24 09:14PM	University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott (PR Newswire)
Dec-05-24 05:50PM	Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
09:30AM	Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet (Zacks)
09:00AM	Loading…
Dec-04-24 09:00AM	Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock (Zacks)
Nov-29-24 05:50PM	Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Nov-27-24 06:00AM	Unlocking Intrinsic Value: Analysis of Abbott Laboratories (GuruFocus.com)
Nov-25-24 04:05PM	InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors (GlobeNewswire)
07:00AM	Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis (PR Newswire)
Nov-22-24 12:21PM	2 Dividend Kings to Buy for a Lifetime of Passive Income (Motley Fool)
Nov-20-24 09:00AM	Is Trending Stock Abbott Laboratories (ABT) a Buy Now? (Zacks)
Nov-19-24 09:30AM	Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy? (Zacks)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
06:00AM	Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland (PR Newswire)
Nov-16-24 07:19PM	Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now (Insider Monkey)
Nov-14-24 06:19AM	3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years (Motley Fool)
Nov-13-24 10:28AM	US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024 (Medical Device Network)
06:00AM	Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories (GuruFocus.com)
Nov-08-24 09:16AM	If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
04:15AM	Loading…
04:15AM	Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever (Motley Fool)
Nov-07-24 10:39AM	Abbott Laboratories (ABT) Makes It On UBS List Of Stocks For The AI, Growth & Low Rates Era (Insider Monkey)
Nov-05-24 09:00AM	Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know (Zacks)
07:26AM	Abbott price target raised to $149 from $143 at Barclays (TipRanks)
Nov-04-24 06:06PM	Is Abbott Laboratories (ABT) the Best Pharma Stock to Buy Right Now? (Insider Monkey)
Nov-01-24 04:09PM	Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial (Investor's Business Daily)
03:55PM	Abbott, Reckitt found not liable in baby formula case. Stocks rise. (Yahoo Finance Video)
11:11AM	Reckitts Mead Johnson, Abbott cleared by US court in infant-formula case (Just Food)
10:24AM	Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win (Investopedia)
09:44AM	Abbott, Reckitt Stocks Rise on Baby-Formula Lawsuit Win (The Wall Street Journal)
07:16AM	Abbott shares rise after securing first win in premature infant formula trial (Reuters)
06:04AM	Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win (The Wall Street Journal)
06:04AM	Reckitt Shares Surge After Baby Formula Lawsuit Win (The Wall Street Journal)
04:59AM	Reckitt, Abbott surge after winning an NEC case (Investing.com)
01:11AM	Decoding Abbott Laboratories (ABT): A Strategic SWOT Insight (GuruFocus.com)
Oct-30-24 09:50AM	New Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes Management (PR Newswire)
08:00AM	Beyond Market Price: Uncovering Abbott Laboratories's Intrinsic Value (GuruFocus.com)
Oct-26-24 07:30AM	3 Dividend Growth Stocks You Can Buy and Hold Forever (Motley Fool)
Oct-25-24 09:10AM	Abbott initiates clinical trial of its CardioMems in advanced heart failure (TipRanks)
Oct-24-24 09:00AM	Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure (PR Newswire)
Oct-23-24 01:03PM	Organic Growth and Margin Expansion Make Abbott Laboratories (ABT) A Solid Investment (Insider Monkey)
09:00AM	Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Oct-19-24 09:57AM	Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever (Motley Fool)
Oct-18-24 03:26PM	Abbott Laboratories (ABT): Strong Q2 Performance and Innovative Product Approvals (Insider Monkey)
09:30AM	Wall Street Analysts Think Abbott (ABT) Is a Good Investment: Is It? (Zacks)
05:10AM	3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now (Motley Fool)
Oct-17-24 02:55PM	Calls of the Day: Crowdstrike, Cheniere Energy, 3M, Abbott Labs, Abbvie and Eli Lilly (CNBC TV)
02:42PM	Abbott Labs Path To Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic (Benzinga)
11:17AM	Abbott reports sales of $10.6bn for Q3 2024 (Medical Device Network)
07:35AM	Abbott reports Q3 Worldwide Medical Devices sales up 11.7% on reported basis (TipRanks)
07:30AM	Is Abbott Laboratories Stock a Buy? (Motley Fool)
03:01AM	Abbott Laboratories (ABT) Q3 2024 Earnings Call Highlights: Strong Growth in Diabetes Care and ... (GuruFocus.com)
01:21AM	Q3 2024 Abbott Laboratories Earnings Call (Thomson Reuters StreetEvents)
Oct-16-24 06:41PM	Why Abbott Laboratories Stock Was a Winner on Wednesday (Motley Fool)
04:14PM	Abbott Labs Stock Rises As Medical Devices Drive Quarterly Beat (Investor's Business Daily)
03:47PM	Analyst Report: Abbott Laboratories (Morningstar Research)
02:17PM	Committee Stocks on the Move: Interactive Brokers, Abbott Labs and Rio Tinto (CNBC TV)
01:45PM	Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript (Motley Fool)
12:15PM	Abbott Laboratories Raises Its Outlook on Strong Medical Device Sales (Investopedia)
12:14PM	Abbott Laboratories Delivers Strong Q3 2024 Results, Raises Full-Year Guidance (GuruFocus.com)
12:10PM	Abbott Laboratories posts Q3 beat, raises profit forecast (Yahoo Finance Video)
10:49AM	Cramer's Stop Trading: Abbott Labs (CNBC TV)
10:21AM	Abbott Posts Solid Quarter. The Stock Is Rising. (Barrons.com)
09:30AM	Here's What Key Metrics Tell Us About Abbott (ABT) Q3 Earnings (Zacks)
09:08AM	Abbott Laboratories' Q3 Earnings: Revenue And EPS Beat, Company Says Well-Positioned To Achieve Upper End Of Annual Forecast (Benzinga)
08:40AM	Abbott (ABT) Q3 Earnings and Revenues Surpass Estimates (Zacks)
08:00AM	The Art of Valuation: Discovering Abbott Laboratories's Intrinsic Value (GuruFocus.com)
07:58AM	Abbott Earnings Edge Past Q3 Views, Led By Medical Devices (Investor's Business Daily)
07:47AM	Abbott Laboratories Boosts FY24 Earnings Outlook - Update (RTT News)
07:38AM	Abbott: Q3 Earnings Snapshot (Associated Press Finance)
07:37AM	Abbott slightly raises profit forecast on strong medical device sales (Reuters)
07:30AM	Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range (PR Newswire)
Oct-15-24 11:48AM	Jim Cramer Says That FDA, NIH, and CDC Comments On Abbott Laboratories (ABT) Could Potential Help The Stock Going Forward (Insider Monkey)
08:46AM	Is a Surprise Coming for Abbott (ABT) This Earnings Season? (Zacks)
Oct-13-24 06:00AM	What To Expect in the Markets This Week (Investopedia)
Oct-11-24 12:38PM	Abbott advances two pulsed field ablation studies for AFib treatment (Medical Device Network)
09:15AM	Abbott (ABT) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
07:14AM	Abbott enrolls pivotal PFA study 4 months ahead of schedule (MedTech Dive)
Oct-10-24 09:00AM	Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping (PR Newswire)
Oct-09-24 10:00AM	Abbott (ABT) Earnings Expected to Grow: Should You Buy? (Zacks)
09:00AM	Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know (Zacks)
07:46AM	Abbott price target raised to $130 from $125 at RBC Capital (TipRanks)
Oct-08-24 06:00PM	Why Abbott (ABT) Outpaced the Stock Market Today (Zacks)
Oct-07-24 11:05AM	Cramer's Stop Trading: Abbott Labs (CNBC TV)
Oct-05-24 09:07AM	Abbott Laboratories (ABT): A Buzzing AI Health Stock to Add to Your Portfolio (Insider Monkey)
04:45AM	Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades (Motley Fool)
Oct-02-24 06:00PM	Abbott (ABT) Outperforms Broader Market: What You Need to Know (Zacks)
08:35AM	Abbott price target raised to $124 from $120 at Evercore ISI (TipRanks)
08:00AM	Beyond Market Price: Uncovering Abbott Laboratories's Intrinsic Value (GuruFocus.com)
04:11AM	Down More Than 50%, Is DexCom Stock a Bargain Now? (Motley Fool)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Funck, Jr. Robert E.	Officer	Nov 04 '24	Proposed Sale	120.00	15,000	1,800,000		Nov 04 04:02 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Oct 21 '24	Option Exercise	47.00	157,421	7,398,787	342,227	Oct 23 05:10 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Oct 21 '24	Sale	117.04	157,421	18,424,298	184,806	Oct 23 05:10 PM
ALLEN HUBERT L	Officer	Oct 21 '24	Proposed Sale	118.89	157,421	18,715,783		Oct 21 04:08 PM
Ford Robert B	CHAIRMAN AND CEO	Sep 12 '24	Option Exercise	47.19	141,679	6,685,975	361,738	Sep 13 05:24 PM
Ford Robert B	CHAIRMAN AND CEO	Sep 12 '24	Sale	116.41	141,679	16,493,218	220,059	Sep 13 05:24 PM
Robert B. Ford	Officer	Sep 12 '24	Proposed Sale	116.41	141,679	16,492,852		Sep 12 06:20 PM
MCCOY JOHN A. JR.	VICE PRESIDENT	Sep 04 '24	Sale	114.83	27	3,100	18,681	Sep 04 07:52 PM
Funck, Jr. Robert E.	Officer	Sep 04 '24	Proposed Sale	115.00	30,000	3,450,000		Sep 04 04:04 PM
Funck, Jr. Robert E.	EXECUTIVE VICE PRESIDENT	May 10 '24	Option Exercise	47.00	10,097	474,559	221,438	May 14 05:35 PM
Funck, Jr. Robert E.	EXECUTIVE VICE PRESIDENT	May 10 '24	Sale	104.57	10,097	1,055,819	211,341	May 14 05:35 PM
Earnhardt Lisa D	EXECUTIVE VICE PRESIDENT	May 07 '24	Sale	106.25	22,852	2,428,119	61,462	May 08 05:00 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Mar 01 '24	Sale	118.50	963	114,116	125,697	Mar 04 07:18 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Mar 01 '24	Sale	118.50	801	94,918	62,968	Mar 04 07:14 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Mar 01 '24	Sale	118.50	676	80,106	91,260	Mar 04 07:09 PM
MCCOY JOHN A. JR.	VICE PRESIDENT	Mar 01 '24	Sale	118.50	472	55,932	18,760	Mar 04 07:05 PM
Earnhardt Lisa D	EXECUTIVE VICE PRESIDENT	Mar 01 '24	Sale	118.50	694	82,239	84,314	Mar 04 06:50 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Mar 01 '24	Sale	118.50	853	101,080	184,806	Mar 04 06:39 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Feb 23 '24	Option Exercise	59.94	12,500	749,250	91,204	Feb 27 06:13 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Feb 23 '24	Sale	120.00	12,500	1,500,000	78,704	Feb 27 06:13 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Jan 29 '24	Option Exercise	50.80	42,500	2,158,950	90,027	Jan 31 05:30 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Jan 29 '24	Sale	112.50	42,500	4,781,250	65,027	Jan 31 05:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABT

Abbott Laboratories

Upgrade your FINVIZ experience